Fundraising Fox

Laura Tadvalkar

Investor

Managing Director, Venture at RA Capital · Board director at HYKU Biosciences

Boston, Massachusetts, United States

Kauffman Fellow · Class 23

Find your path to Laura

988 people in our graph share verified history with Laura — schools, employers, funds. One of them is your warm intro.

Crystal HuangunlockedLaura: together at Harvard University (2009–2011)
×8Laura: together at Kauffman Fellows
×2Laura: together at Harvard University
Laura: together at Yale University

About

Laura Tadvalkar is a health economist and policy analyst serving as Senior Economic and Policy Advisor at No Patient Left Behind. Her work involves applying quantitative and qualitative research methods to public health policy and to the commercialization of pharmaceutical products.

Board director at HYKU Biosciences

Intro paths

→

In turn, Laura can intro founders to HYKU Biosciences's investors below.

HYKU Biosciences's investors · 4

Droia VenturesLeuven · $540K checks · since 2025Eisai Innovation, Inc.San Francisco · since 2025Novartis Venture FundBasel · $5M – $25M checks · since 2025RA CapitalBoston · since 2025

Co-founders at HYKU Biosciences

KCKLEEM CHAUDHARY
KLEEM CHAUDHARYExecutive Officer, Director, Promoter
K(Ku-Lung (Ken) Hsu, PhD
Ku-Lung (Ken) Hsu, PhDEndowed Associate Professor of Chemistry

Experience

  1. RA Capital Management, L.P.Managing Directorcurrent2023 — present
  2. RA Capital Management, L.P.Principal2020 — 2023
  3. RA Capital Management, L.P.Venture Senior Associate2020
  4. NorthLinks BioBoard Directorcurrent2026 — present
  5. Imbria PharmaceuticalsBoard Directorcurrent2026 — present
  6. GIVAX, Inc.Board Directorcurrent2026 — present
  7. Typewriter Therapeutics, Inc.Board Directorcurrent2023 — present
  8. PepGenBoard Observercurrent2020 — present
  9. Hemab TherapeuticsBoard Director2021 — 2026
  10. Hyku BiosciencesBoard Director2021 — 2026
  11. Be BiopharmaBoard Director, Former Board Observer2020 — 2026
  12. Cidara TherapeuticsBoard Director2024 — 2025
  13. Expansion TherapeuticsBoard Director2021 — 2025
  14. Mariana OncologyBoard Director, Former Board Observer2021 — 2024
  15. Aliada TherapeuticsBoard Chair2021 — 2024
  16. Aerovate Therapeutics, Inc.Board Observer2020 — 2021
  17. Kauffman FellowsKauffman Fellow, Class 232018 — 2021
  18. MP Healthcare Venture Management (MPH)Principal2019 — 2020
  19. MP Healthcare Venture Management (MPH)Senior Associate2017 — 2019
  20. QurAlisBoard Observer2019 — 2020
  21. Sonde Health, Inc.Board Observer2019 — 2020
  22. Ribometrix Inc.Board Observer, Interim Director of BD2017 — 2020
  23. Clarion | A Life Sciences ConsultancyManager2017
  24. Clarion | A Life Sciences ConsultancyConsultant2015 — 2016
  25. Clarion | A Life Sciences ConsultancyAssociate Consultant2014 — 2015

Skills & more

Rare DiseasesOncology1BiopharmaceuticalsOpportunity AssessmentLaunch StrategiesForecastingStrategy1Combination ProductsHealthcare ConsultingRecruitingProtein Chemistry9Molecular Biology8
+9 moreBiochemistryMolecular CloningCell BiologyChemical BiologyMetabolomicsRNAiProtein Expression and PurificationMitochondrial and Metabolic DisordersBiotechnology

From Laura's professional profile.

Colleagues at RA Capital

Abigail Schmitz
Senior Associate, Corporate Development at RA Capital
Adam Kaye
Senior Managing Director and Partner, Structured Capital at RA Capital
Adrian Bot
Venture Partner at RA Capital
Albert Kim
Advisor at RA Capital
Alex Miller
Senior Associate, Venture at RA Capital
Alex Zhang
Vice President, Structured Capital at RA Capital
Alison Tisdale
Advisor at RA Capital
Alyssa Larson
Investor at RA Capital

Network1

Jeffrey MooreMentor
President at MC Healthcare Ventures

Investors connected to Laura in public investor directories — a warm-intro map.

Frequently asked questions

Who is Laura Tadvalkar?
Laura Tadvalkar is a health economist and policy analyst serving as Senior Economic and Policy Advisor at No Patient Left Behind. Her work involves applying quantitative and qualitative research methods to public health policy and to the commercialization of pharmaceutical products.
Where does Laura Tadvalkar work?
Laura Tadvalkar is Managing Director, Venture at RA Capital and Board director at HYKU Biosciences.
Where did Laura Tadvalkar go to school?
Laura Tadvalkar studied at Harvard University (Doctor of Philosophy (Ph.D.), Chemical Biology); Yale University (BS, cum laude, Chemistry (with distinction in the major)).

Same school

Also attended Harvard University2,000

Ron ConwayFounder of SV AngelAlfred LinPartner at Sequoia CapitalChris DixonFounder & Managing Partner of a16z crypto at Andreessen HorowitzSarah TavelVenture Partner at BenchmarkDanny RimerPartner at Index VenturesLaela SturdyManaging Partner at CapitalG

+ 1,994 more

Also attended Yale University1,080

Ann Miura-KoCo-founding Partner at FloodgateDavid SzeAdvisory Partner at GreylockMichael SeibelPartner Emeritus at Y CombinatorBen SilbermannCo-founder of PinterestZheela QaiserInvestor at Index VenturesAnthony PhilippakisInvestor at GV (Google Ventures)

+ 1,074 more

Shared employers

Also worked at NorthLinks Bio2

Fanny CavaliéChief Executive Officer at NorthLinks BioJohn BeadleCo-founder at Vitarka Therapeutics

Also worked at GIVAX, Inc.3

Mario BarroVenture Partner at RA CapitalFanny CavaliéChief Executive Officer at NorthLinks BioJohn PattonScientific Co-Founder at GIVAX

Also worked at Expansion Therapeutics2

Jason RuthPartner at MRL Ventures FundDr. Gunes BozkurtDirector of Venture Investments & Lead of Life Science Investments at Beiersdorf Innovation Fund

Also worked at Kauffman Fellows538

Jenny LeeSenior Managing Partner at Granite AsiaRoi Bar-KatManaging Director at Intel CapitalAvi BharadwajInvestment Director at Intel CapitalNick WashburnSenior Managing Director, Intel Capital (North America)Justin HallPartner at Golden Gate VenturesMichael LintsFounding Partner, MENA at Golden Gate Ventures

+ 532 more